FIELD: medicine. SUBSTANCE: method involves administering carcynin as preparation possessing antioxidation activity. Carcynin is parabulbarily administered at once a day during 5 days. EFFECT: prevented internal retina boundary membrane destruction. 3 cl, 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR MODELING PROLIFERATIVE VITRORETINOPATHY | 1998 |
|
RU2161335C2 |
| METHOD FOR SIMULATING PROLIFERATIVE VITREORETINOPATHY | 2014 |
|
RU2568368C1 |
| METHOD FOR THE TREATMENT OF PROLIFERATIVE PROCESSES OF THE POSTERIOR SEGMENT OF THE EYE | 2018 |
|
RU2684927C1 |
| METHOD FOR TREATING PROLIFERATIVE VITREORETINOPATHY USING LIPOSOME-ASSOCIATED MELPHALAN IN AN EXPERIMENT | 2021 |
|
RU2772520C1 |
| METHOD OF TREATING ENDOPHTHALMITES | 1998 |
|
RU2164115C2 |
| METHOD FOR TREATING RETINAL VEIN THROMBOSIS BY ADMINISTERING NITROGEN OXIDE DONORS AND INHIBITORS | 2002 |
|
RU2223072C2 |
| DRAIN FOR TREATING THE CASES OF AMOTIO RETINAE RECURRENCE | 2001 |
|
RU2192822C1 |
| METHOD FOR PREDICTING DEVELOPMENT OF VISUAL FUNCTIONS AT RETINOPATHY IN PREMATURE CHILDREN | 2000 |
|
RU2210307C2 |
| METHOD FOR STIMULATING NEOVASCULARISATION OF RETINA AND OPTIC NERVE IN RABBITS | 2009 |
|
RU2408083C1 |
| METHOD FOR TREATING PROLIFERATIVE VITREORETINOPATHY | 2005 |
|
RU2284812C1 |
